Kymera Therapeutics

Oxford Global’s Virtual Symposium: Targeted Protein Degradation & PROTAC, February 16-17, 2021

Poster Presentation: Discovery of Potent and Selective STAT3 Targeted Protein Degraders with Excellent in vitro and in vivo ADME Properties